Research graph
References from MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21654
10.3322/caac.21654 · External reference
10.1016/j.ctrv.2020.102087
10.1016/j.ctrv.2020.102087 · External reference
10.1007/s11912-017-0615-4
10.1007/s11912-017-0615-4 · External reference
10.3238/arztebl.2018.0646
10.3238/arztebl.2018.0646 · External reference
10.1016/j.juro.2006.11.038
10.1016/j.juro.2006.11.038 · External reference
10.1093/annonc/mds635
10.1093/annonc/mds635 · External reference
10.1200/jco.2010.29.5477
10.1200/jco.2010.29.5477 · External reference
10.3390/diagnostics10090694
10.3390/diagnostics10090694 · External reference
10.1016/j.humpath.2013.07.012
10.1016/j.humpath.2013.07.012 · External reference
10.1371/journal.pone.0062175
10.1371/journal.pone.0062175 · External reference
10.1016/j.clgc.2015.10.010
10.1016/j.clgc.2015.10.010 · External reference
10.4103/0973-1482.151945
10.4103/0973-1482.151945 · External reference
10.1097/cad.0000000000000024
10.1097/cad.0000000000000024 · External reference
10.1002/ijc.70249
10.1002/ijc.70249 · External reference
10.3389/fimmu.2022.1055235
10.3389/fimmu.2022.1055235 · External reference
10.3390/jcm9103334
10.3390/jcm9103334 · External reference
10.1038/s41585-020-0359-z
10.1038/s41585-020-0359-z · External reference
10.1007/s00345-020-03510-7
10.1007/s00345-020-03510-7 · External reference
10.1016/j.asjsur.2021.12.048
10.1016/j.asjsur.2021.12.048 · External reference
10.6004/jnccn.2024.7074
10.6004/jnccn.2024.7074 · External reference
10.1093/jnci/djad155
10.1093/jnci/djad155 · External reference
Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis
10.1186/s40164-025-00629-4 · 2025 · External reference
10.1016/j.ccell.2025.03.023
10.1016/j.ccell.2025.03.023 · External reference
10.3389/fimmu.2026.1731920
10.3389/fimmu.2026.1731920 · External reference
10.1001/jamaoncol.2025.3266
10.1001/jamaoncol.2025.3266 · External reference
10.1038/s41467-025-63269-6
10.1038/s41467-025-63269-6 · External reference
10.1021/jacs.4c06189
10.1021/jacs.4c06189 · External reference
10.1158/1535-7163.mct-17-0749
10.1158/1535-7163.mct-17-0749 · External reference
10.1158/1078-0432.ccr-22-1989
10.1158/1078-0432.ccr-22-1989 · External reference
10.1158/0008-5472.can-23-2812
10.1158/0008-5472.can-23-2812 · External reference
10.1186/s13058-022-01587-z
10.1186/s13058-022-01587-z · External reference
10.1182/blood-2017-10-811224
10.1182/blood-2017-10-811224 · External reference
10.1001/jamaoncol.2025.3266
10.1001/jamaoncol.2025.3266 · ExternalCitation · doi-reference
10.1002/ijc.70249
10.1002/ijc.70249 · ExternalCitation · doi-reference
10.1007/s00345-020-03510-7
10.1007/s00345-020-03510-7 · ExternalCitation · doi-reference
10.1007/s11912-017-0615-4
10.1007/s11912-017-0615-4 · ExternalCitation · doi-reference
10.1016/j.asjsur.2021.12.048
10.1016/j.asjsur.2021.12.048 · ExternalCitation · doi-reference
10.1016/j.ccell.2025.03.023
10.1016/j.ccell.2025.03.023 · ExternalCitation · doi-reference
10.1016/j.clgc.2015.10.010
10.1016/j.clgc.2015.10.010 · ExternalCitation · doi-reference
10.1016/j.ctrv.2020.102087
10.1016/j.ctrv.2020.102087 · ExternalCitation · doi-reference
10.1016/j.humpath.2013.07.012
10.1016/j.humpath.2013.07.012 · ExternalCitation · doi-reference
10.1016/j.juro.2006.11.038
10.1016/j.juro.2006.11.038 · ExternalCitation · doi-reference
10.1021/jacs.4c06189
10.1021/jacs.4c06189 · ExternalCitation · doi-reference
10.1038/s41467-025-63269-6
10.1038/s41467-025-63269-6 · ExternalCitation · doi-reference
10.1038/s41585-020-0359-z
10.1038/s41585-020-0359-z · ExternalCitation · doi-reference
10.1093/annonc/mds635
10.1093/annonc/mds635 · ExternalCitation · doi-reference
10.1093/jnci/djad155
10.1093/jnci/djad155 · ExternalCitation · doi-reference
10.1097/cad.0000000000000024
10.1097/cad.0000000000000024 · ExternalCitation · doi-reference
10.1158/0008-5472.can-23-2812
10.1158/0008-5472.can-23-2812 · ExternalCitation · doi-reference
10.1158/1078-0432.ccr-22-1989
10.1158/1078-0432.ccr-22-1989 · ExternalCitation · doi-reference
10.1158/1535-7163.mct-17-0749
10.1158/1535-7163.mct-17-0749 · ExternalCitation · doi-reference
10.1182/blood-2017-10-811224
10.1182/blood-2017-10-811224 · ExternalCitation · doi-reference
10.1186/s13058-022-01587-z
10.1186/s13058-022-01587-z · ExternalCitation · doi-reference
Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis
10.1186/s40164-025-00629-4 · ExternalCitation · doi-reference
10.1200/jco.2010.29.5477
10.1200/jco.2010.29.5477 · ExternalCitation · doi-reference
10.1371/journal.pone.0062175
10.1371/journal.pone.0062175 · ExternalCitation · doi-reference
10.3238/arztebl.2018.0646
10.3238/arztebl.2018.0646 · ExternalCitation · doi-reference
10.3322/caac.21654
10.3322/caac.21654 · ExternalCitation · doi-reference
10.3389/fimmu.2022.1055235
10.3389/fimmu.2022.1055235 · ExternalCitation · doi-reference
10.3389/fimmu.2026.1731920
10.3389/fimmu.2026.1731920 · ExternalCitation · doi-reference
10.3390/diagnostics10090694
10.3390/diagnostics10090694 · ExternalCitation · doi-reference
10.3390/jcm9103334
10.3390/jcm9103334 · ExternalCitation · doi-reference
10.4103/0973-1482.151945
10.4103/0973-1482.151945 · ExternalCitation · doi-reference
10.6004/jnccn.2024.7074
10.6004/jnccn.2024.7074 · ExternalCitation · doi-reference
